Nabriva Therapeutics plc (NBRV) Rose 6.68% or 0.39 To Price $6.23 On Thursday


Nabriva Therapeutics plc (NBRV) rose 6.68% or 0.39 to $6.23. It is close to 214634 shares traded, which is 116.43% compare to the average total volume 184339. The market cap of NBRV is $228.59 million. The year to date change is -8.18%. The 52 week price range is from $4.75 to $14.1. Price of NBRV have changed 7.16% during last week. It have changed 1.92% over last month, 0.86% over last 3 months, -30.56% over last 6 months and -50.09% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for NBRV is 6.05. It is -2.89% below current price. The 200-day Moving Averages for NBRV is 7.76. It is 24.56% above current price. The 52-week High is 14.1. It is 126.32% from the current price. The 52-week Low is 4.75. It is -23.76% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of NBRV is 4.22 on 2018-02-15. Short % to float is 2.21%. There are some statistics of NBRV. It is has market cap $228.59 million. The share outstanding is 36.69 million. The average volume is 184339. The revenue is 6.50M. The percent of top 15 Institution holding is 12.00%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of NBRV is -77.24%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of NBRV is -65.57%.


Tags:

Share this post